Descemet Membrane Endothelial Keratoplasty (DMEK)
Launched by NETHERLANDS INSTITUTE FOR INNOVATIVE OCULAR SURGERY · Aug 24, 2007
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
See above.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Corneal endothelial disorders
- Exclusion Criteria:
- • N/A
About Netherlands Institute For Innovative Ocular Surgery
The Netherlands Institute for Innovative Ocular Surgery is a leading research organization dedicated to advancing the field of ophthalmic surgery through innovative clinical trials and cutting-edge technologies. Focused on enhancing patient outcomes, the institute collaborates with renowned experts and institutions to develop novel surgical techniques and therapies for various ocular conditions. By integrating rigorous scientific methodologies with a commitment to patient-centered care, the institute aims to transform the landscape of ocular surgery and improve the quality of life for individuals with vision impairments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, , Netherlands
Patients applied
Trial Officials
Gerrit R Melles, MD, PhD
Principal Investigator
Netherlands Institute for Innovative Ocular Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials